Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.

Source:http://linkedlifedata.com/resource/pubmed/id/15028248

Download in:

View as

General Info

PMID
15028248